Dyson PJ - Search Results

1

Screening-based approach to discover effective platinum-based chemotherapies for cancers with poor prognosis.

Varbanov HP, Kuttler F, Banfi D, Turcatti G, Dyson PJ. Varbanov HP, et al. Among authors: dyson pj. PLoS One. 2019 Jan 29;14(1):e0211268. doi: 10.1371/journal.pone.0211268. eCollection 2019. PLoS One. 2019. PMID: 30695050 Free PMC article.

2

Rapid optimization of drug combinations for the optimal angiostatic treatment of cancer.

Weiss A, Ding X, van Beijnum JR, Wong I, Wong TJ, Berndsen RH, Dormond O, Dallinga M, Shen L, Schlingemann RO, Pili R, Ho CM, Dyson PJ, van den Bergh H, Griffioen AW, Nowak-Sliwinska P. Weiss A, et al. Among authors: dyson pj. Angiogenesis. 2015 Jul;18(3):233-44. doi: 10.1007/s10456-015-9462-9. Epub 2015 Apr 1. Angiogenesis. 2015. PMID: 25824484 Free PMC article.

3

Metal-based drugs that break the rules.

Allardyce CS, Dyson PJ. Allardyce CS, et al. Among authors: dyson pj. Dalton Trans. 2016 Feb 28;45(8):3201-9. doi: 10.1039/c5dt03919c. Epub 2016 Jan 28. Dalton Trans. 2016. PMID: 26820398 Free article. Review.

4

Repositioning approved drugs for the treatment of problematic cancers using a screening approach.

Varbanov HP, Kuttler F, Banfi D, Turcatti G, Dyson PJ. Varbanov HP, et al. Among authors: dyson pj. PLoS One. 2017 Feb 6;12(2):e0171052. doi: 10.1371/journal.pone.0171052. eCollection 2017. PLoS One. 2017. PMID: 28166232 Free PMC article.

5

Oxaliplatin reacts with DMSO only in the presence of water.

Varbanov HP, Ortiz D, Höfer D, Menin L, Galanski MS, Keppler BK, Dyson PJ. Varbanov HP, et al. Among authors: dyson pj. Dalton Trans. 2017 Jul 18;46(28):8929-8932. doi: 10.1039/c7dt01628j. Dalton Trans. 2017. PMID: 28654098 Free PMC article.

6

Drug Repurposing Approach Identifies a Synergistic Drug Combination of an Antifungal Agent and an Experimental Organometallic Drug for Melanoma Treatment.

Riedel T, Demaria O, Zava O, Joncic A, Gilliet M, Dyson PJ. Riedel T, et al. Among authors: dyson pj. Mol Pharm. 2018 Jan 2;15(1):116-126. doi: 10.1021/acs.molpharmaceut.7b00764. Epub 2017 Dec 13. Mol Pharm. 2018. PMID: 29185769 Free article.

7

Multifunctional Pt(iv) prodrug candidates featuring the carboplatin core and deferoxamine.

Harringer S , Hejl M , Enyedy ÉA , Jakupec MA , Galanski MS , Keppler BK , Dyson PJ , Varbanov HP . Harringer S , et al. Among authors: dyson pj. Dalton Trans. 2021 Jun 21;50(23):8167-8178. doi: 10.1039/d1dt00214g. Epub 2021 May 25. Dalton Trans. 2021. PMID: 34031671

8

Rational design of platinum(IV) compounds to overcome glutathione-S-transferase mediated drug resistance.

Ang WH, Khalaila I, Allardyce CS, Juillerat-Jeanneret L, Dyson PJ. Ang WH, et al. Among authors: dyson pj. J Am Chem Soc. 2005 Feb 9;127(5):1382-3. doi: 10.1021/ja0432618. J Am Chem Soc. 2005. PMID: 15686364

9

In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes.

Scolaro C, Bergamo A, Brescacin L, Delfino R, Cocchietto M, Laurenczy G, Geldbach TJ, Sava G, Dyson PJ. Scolaro C, et al. Among authors: dyson pj. J Med Chem. 2005 Jun 16;48(12):4161-71. doi: 10.1021/jm050015d. J Med Chem. 2005. PMID: 15943488

10

Synthesis and characterization of platinum(IV) anticancer drugs with functionalized aromatic carboxylate ligands: influence of the ligands on drug efficacies and uptake.

Ang WH, Pilet S, Scopelliti R, Bussy F, Juillerat-Jeanneret L, Dyson PJ. Ang WH, et al. Among authors: dyson pj. J Med Chem. 2005 Dec 15;48(25):8060-9. doi: 10.1021/jm0506468. J Med Chem. 2005. PMID: 16335930

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

457 results

Search Page